Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression (vol 88, pg 131, 2015)

• Authors: Kaisheng Mao, Emory University; Fakeng Liu, Emory University; Xiuju Liu, Emory University; Fadlo Khuri, Emory University; Adam Marcus, Emory University; Mingsong Li, NanFang Hospital; Wei Zhou, Emory University
• Journal Title: Lung Cancer
• Volume: Volume 154
• Publisher: Elsevier Ireland Ltd. | 2021-04-02, Pages 228-228
• Type of Work: Article | Post-print: After Peer Review
• Publisher DOI: http://doi.org/10.1016/j.lungcan.2021.02.013
• Subjects: Health Sciences, Oncology; Health Sciences, Health Care Management; Health Sciences, Medicine and Surgery
• Keywords: Science & Technology; Life Sciences & Biomedicine; Oncology; Respiratory System

Abstract

The authors regret that there was an error in the labelling of plasmid K78I. All the cell lines containing mutant LKB1 should be labelled K78I, not K78M, throughout this article. The authors would like to apologise for any inconvenience caused.